Do adjusted clinical groups eliminate incentives for HMOs to avoid substance abusers? Evidence from the Maryland

Susan L Ettner1, Steven Johnson

  • 1UCLA Department of Medicine, Division of General Internal Medicine & Health Services Research, 911 Broxton Plaza, Room 106, Box 951736, Los Angeles, CA 90095-1736, USA. settner@mednet.ucla.edu

Insights

Managed care organizations (MCOs) may still avoid enrolling patients with substance use disorders despite risk adjustment. This study found that while risk adjustment reduced, it did not eliminate, financial incentives for MCOs to avoid these costly beneficiaries.

Area of Science:

  • Health Services Research
  • Public Health Policy
  • Healthcare Economics

Background:

  • Managed care organizations (MCOs) face scrutiny regarding risk adjustment adequacy.
  • Incentives for MCOs to avoid enrolling high-cost patients, particularly those with substance use disorders, remain a concern.
  • The Maryland Medicaid HealthChoice program's risk adjustment methodology is examined.

Purpose of the Study:

  • To investigate expenditure differences between beneficiaries with and without substance use disorders.
  • To assess whether risk adjustment effectively eliminates MCO incentives to avoid substance-abusing enrollees.
  • To evaluate the Maryland Medicaid HealthChoice program's adjusted clinical groups (ACG) methodology.

Main Methods:

  • Utilized Maryland Medicaid data from fiscal years 1995-1997.
  • Assigned beneficiaries to capitation rate groups based on FY1995 diagnoses.
  • Compared expenditures for beneficiaries with and without substance use disorders (defined by FY1995 and FY1997 diagnoses).

Main Results:

  • Expenditure differences in FY1997 between beneficiaries with and without prior substance use disorders were minimal.
  • MCOs faced potential for greater average losses and reduced average profits with substance-abusing beneficiaries in FY1997.
  • The ACG methodology attenuated, but did not fully remove, financial disincentives for MCOs to enroll substance users.

Conclusions:

  • Risk adjustment in the HealthChoice program partially mitigates, but does not eliminate, MCOs' financial incentives to avoid substance abusers.
  • Further refinement of risk adjustment models may be necessary to ensure equitable care access for vulnerable populations.
  • Substance use disorders continue to present financial challenges for MCOs under current risk adjustment systems.

Related Concept Videos

Healthcare Agencies II01:17

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Documentation in Long-Term and Home Healthcare Setting01:29

Documentation in Long-Term and Home Healthcare Setting

Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities